Skip to main content
. 2018 Feb 20;7(2):168–175. doi: 10.1016/j.imr.2018.02.004

Fig. 1.

Fig. 1

Primary and secondary antibody titres across all the groups.

Nanocurc, nanocurcumin; Free-curc, free curcumin. Similar superscripts denote no significant difference (p > 0.05) while different superscripts denote significant difference (p < 0.05).